Japan to review drug prices annually vs every two years previously: sources

TOKYO (Reuters) - The Japanese government plans to start reviewing drug prices every year, instead of every two years, in a bid to reduce mounting healthcare costs, government officials with direct knowledge of the decision said on Monday.